Derek Gerard Power
University College Cork · 306 works · 6,692 citations · h-index 39
Top works
- Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
- Pooled Analysis Safety Profile of Nivolumab and Ipilimumab Combination Therapy in Patients With Advanced Melanoma
- Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later
- Advanced gastric cancer – Slow but steady progress
- New-Onset Mediastinal and Central Nervous System Sarcoidosis in a Patient with Metastatic Melanoma Undergoing CTLA4 Monoclonal Antibody Treatment
- Trimodality therapy versus perioperative chemotherapy in the management of locally advanced adenocarcinoma of the oesophagus and oesophagogastric junction (Neo-AEGIS): an open-label, randomised, phase 3 trial
- Adjuvant vemurafenib in resected, BRAFV600 mutation-positive melanoma (BRIM8): a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial
- The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma
- Effects of weight loss and sarcopenia on response to chemotherapy, quality of life, and survival
- Role of Adjuvant Therapy After Resection of Colorectal Cancer Liver Metastases
- ICORG 10-14: Neo-AEGIS: A randomized clinical trial of neoadjuvant and adjuvant chemotherapy (modified MAGIC regimen) versus neoadjuvant chemoradiation (CROSS protocol) in adenocarcinoma of the esophagus and esophagogastric junction.
- Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer
- Barrett Esophagus
- Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib
- Obesity, metabolic syndrome and esophageal adenocarcinoma: Epidemiology, etiology and new targets
- Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition?
- Adjuvant nab -Paclitaxel + Gemcitabine in Resected Pancreatic Ductal Adenocarcinoma: Results From a Randomized, Open-Label, Phase III Trial
- A national survey of oncology survivors examining nutrition attitudes, problems and behaviours, and access to dietetic care throughout the cancer journey
- Poor Awareness of Risk Factors for Cancer in Irish Adults: Results of a Large Survey and Review of the Literature
- Glycolysis inhibition as a cancer treatment and its role in an anti-tumour immune response